We also observed that the levels of sHER2 are positively correlated with that of tumor HER2 in CRC patients (p<0.05, Figure 1D), considering that measurement of sHER2 may be used to reflect the levels of HER2 in tumors as a reference during cancer therapy. The gene discussed is ERBB2; the disease is cancer.